Jane Street
XERS icon

Jane Street’s Xeris Biopharma Holdings XERS Stock Holding History

Jane Street’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$99.8K Sell
12,600
-5,900
-32% -$37.7K ﹤0.01% 10596
2026
Q1 		$107K Buy
+18,500
New +$123K ﹤0.01% 10611
2022
Q2 		– Sell
-10,300
Closed -$26K – 11062
2022
Q1 		$26K Sell
10,300
-12,800
-55% -$31.3K ﹤0.01% 9875
2021
Q4 		$68K Buy
+23,100
New +$49.9K ﹤0.01% 9409
2021
Q3 		– Sell
-45,900
Closed -$187K – 10851
2021
Q2 		$187K Buy
+45,900
New +$175K ﹤0.01% 8883

Other funds holding XERS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Jane Street's XERS Position: Q2 2026 in Review

Jane Street reduced its Xeris Biopharma Holdings (XERS) stake by 91% in Q2 2026, selling an estimated $4.24M and leaving 61,915 shares worth $490K. The position accounts for ﹤0.01% of the portfolio, ranked #8077.

Jane Street first reported a position in XERS in Q4 2020 and has held it in 23 quarters since. The position peaked at $7.44M in Q3 2025. 241 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

  • Jane Street held 61,915 shares of Xeris Biopharma Holdings worth $490K as of Q2 2026.
  • Jane Street sold 663,701 Xeris Biopharma Holdings shares in Q2 2026, an estimated $4.24M.
  • Xeris Biopharma Holdings made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #8077 holding.
  • Jane Street first reported a position in Xeris Biopharma Holdings in Q4 2020 and has held it in 23 quarters since.
  • Jane Street's Xeris Biopharma Holdings position peaked at $7.44M in Q3 2025.
  • 241 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.